Web Exclusive

China Resources Group eyes bio-medical sector

By Qiang Xiaoji (chinadaily.com.cn)
Updated: 2010-07-30 17:18
Large Medium Small

The State-owned Assets Supervision and Administration Commission (SASAC) of Beijing and the China Resources Group in Hong Kong agreed Friday to cooperate in the bio-medical sector, the financial website Caing.com reported Friday.

Related readings:
China Resources Group eyes bio-medical sector China Resources to buy HK coffee chain
China Resources Group eyes bio-medical sector China Resources, Tianjin Gas agree to $590m venture
China Resources Group eyes bio-medical sector China Resources Q1 net surges on robust sales
China Resources Group eyes bio-medical sector China Resources Land earnings double to HK$4.41b

A source close to the matter said that China Resources Medication Group under China Resources Group will hold 100 percent of the shares of Beijing Pharmaceutical Group Co. In return, SASAC of Beijing will hold 28 percent of China Resources Medication Group's shares and China Resources Group's shareholdings in China Resources Medication Group will be reduced to 72 percent.

China Resources Group plans to include the medical sector as its new profit growth point, the report said.

Song Lin, president of China Resources Group, said they will list China Resources Medication Group in at least two to three years, according to the report.